AMBER ALERT: Severely autistic 9-year-old boy last seen in Davison Township [MORE]

High Cholesterol

Esperion Therapeutics

Esperion Therapeutics Presents Promising Test Results On Cholesterol Drug

The pharma startup Esperion Therapeutics Inc. Monday announced full results of a Phase 2 clincal study of its lead drug candidate, called ETC-1002. The drug is intended to reduce high cholesterol levels in patients with a history of intolerance to today’s cholesterol-lowering statin drugs.

WWJ Newsradio 950–11/18/2013